TScan Therapeutics (TCRX) Common Equity (2020 - 2026)
TScan Therapeutics' Common Equity was $38.01 million in Q3 2026, down 73.6% from $144.02 million a year earlier and down 44.9% from the prior quarter.
TScan Therapeutics (TCRX) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at TScan Therapeutics came in at $123.12 million, down 48.9% from FY2024.
- In earlier years, Common Equity was $240.97 million in FY2024 (+59.7%), $150.87 million in FY2023 (+51.7%), $99.43 million in FY2022 (-38.2%) and $160.78 million in FY2021.
- The Q3 2026 figure marks the lowest quarterly Common Equity since Q2 2021.
- Compared with a year earlier, Common Equity has declined for six straight quarters, with an average decline of 21.8% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q1 2025 (growth of 70.9%); the worst was Q3 2026 (a decline of 73.6%).
- Per Business Quant data, TCRX's Common Equity in the three quarters before Q3 2026 was $69.02 million (Q2 2026), $96.92 million (Q1 2026) and $123.12 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -159,093.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 40.27 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 81.53 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | -4.58 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 44.95 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | 24.30 Bn |
| 10 | TScan Therapeutics | 18.87 Mn | -434.83 Mn | - | 38.01 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 38.01 Mn |
| Jun 30, 2026 | 69.02 Mn |
| Mar 31, 2026 | 96.92 Mn |
| Dec 31, 2025 | 123.12 Mn |
| Sep 30, 2025 | 144.02 Mn |
| Jun 30, 2025 | 176.71 Mn |
| Mar 31, 2025 | 210.20 Mn |
| Dec 31, 2024 | 240.97 Mn |
| Sep 30, 2024 | 229.09 Mn |
| Jun 30, 2024 | 255.22 Mn |
| Mar 31, 2024 | 122.97 Mn |
| Dec 31, 2023 | 150.87 Mn |
| Sep 30, 2023 | 168.96 Mn |
| Jun 30, 2023 | 190.61 Mn |
| Mar 31, 2023 | 78.02 Mn |
| Dec 31, 2022 | 99.43 Mn |
| Sep 30, 2022 | 116.66 Mn |
| Jun 30, 2022 | 131.65 Mn |
| Mar 31, 2022 | 145.69 Mn |
| Dec 31, 2021 | 160.78 Mn |
TScan Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=TCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();